Clinical Trial Update: Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium [Phase 1]

View source ↗

Summary

A Phase 1 trial from MD Anderson Cancer Center evaluated short-term low-dose interferon alfa in patients with urothelial cancers (bladder and urethral cancer) a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urethral Cancer

Drugs mentioned

• Interferon Alfa (interferon alfa)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer, Urethral Cancer | Phase 1 | Status: COMPLETED